发明授权
- 专利标题: Rationally designed antibodies
- 专利标题(中): 合理设计的抗体
-
申请号: US12321828申请日: 2009-01-26
-
公开(公告)号: US08771932B2公开(公告)日: 2014-07-08
- 发明人: Katherine S. Bowdish , Mark Renshaw , Shana Frederickson
- 申请人: Katherine S. Bowdish , Mark Renshaw , Shana Frederickson
- 申请人地址: US CT Cheshire
- 专利权人: Alexion Pharmaceuticals, Inc.
- 当前专利权人: Alexion Pharmaceuticals, Inc.
- 当前专利权人地址: US CT Cheshire
- 代理机构: Nelson Mullins Riley & Scarborough LLP
- 代理商 Jane E. Remillard, Esq.; Christopher L. Frank
- 主分类号: A61K35/14
- IPC分类号: A61K35/14 ; C07K16/00 ; C07K7/00
摘要:
Antibodies or fragments thereof having CDR regions replaced or fused with biologically active peptides are described. Flanking sequences may optionally be attached at one or both the carboxy-terminal and amino-terminal ends of the peptide in covalent association with adjacent framework regions. Compositions containing such antibodies or fragments thereof are useful in therapeutic and diagnostic modalities.
公开/授权文献
- US20100041012A1 Rationally designed antibodies 公开/授权日:2010-02-18
信息查询
IPC分类: